COMMUNIQUÉS West-GlobeNewswire

Mobia Medical Announces Pricing of Initial Public Offering
08/05/2026
AUSTIN, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI) (“Mobia Medical”), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor [...]
LifeStance Health Group Announces Pricing of Secondary Public Offering
08/05/2026
SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health [...]
MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results
08/05/2026
TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS ) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids [...]
Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering
08/05/2026
BOSTON, May 07, 2026 (GLOBE NEWSWIRE) -- Odyssey Therapeutics, Inc. (“Odyssey”), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and [...]
Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/05/2026
BOSTON, May 07, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), today announced that, on May 3, 2026, the Company granted inducement equity awards to seven new employees, including its newly appointed [...]
InnoCare Announces Approval of a Phase II Clinical Trial of TYK2 Inhibitor ICP-488 for Sjögren's Syndrome in China
08/05/2026
BEIJING, May 07, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today the approval of the [...]
Nova Leap Health Corp. Posts Q1 2026 Results
07/05/2026
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 07, 2026 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]
NetraMark Announces Change To Board Of Directors
07/05/2026
TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) , a premier artificial intelligence (AI) company transforming clinical trials [...]
Cognition Therapeutics Reports Financial Results for the First Quarter 2026 and Provides Business Update
07/05/2026
Meeting with FDA Division of Psychiatry scheduled for May 2026 expected to inform registrational plans for zervimesine in DLB psychosis PURCHASE, N.Y., May 07, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. ( [...]
Extendicare Announces 2026 First Quarter Results
07/05/2026
MARKHAM, Ontario, May 07, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three months ended March 31, 2026. First Quarter 2026 Highlights Adjusted [...]
VitalHub Reports First Quarter 2026 Results
07/05/2026
Annual Recurring Revenue (“ARR”)⁽¹⁾ up 34% YoY to $99.1 million Total Revenue up 47% YoY to $31.9 million Adjusted EBITDA⁽¹⁾ up 42% YoY to $8.0 million TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI [...]
STERIS Appoints Pierre Boulud to Board of Directors
07/05/2026
DUBLIN, IRELAND, May 07, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that, effective May 5, 2026, Pierre Boulud has been appointed to the Board of Directors. “We are [...]
Globus Medical Reports First Quarter 2026 Results
07/05/2026
AUDUBON, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the first quarter ended March 31, 2026. First [...]
Tarsus to Participate in Upcoming Investor Conferences
07/05/2026
IRVINE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences: Bank of America [...]
VitalHub Announces Planned Board Succession with Appointment of Allan Brett as Chairman
07/05/2026
TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today proposed changes to its Board of Directors (the “Board”) in connection with the Company’s [...]
LifeStance Health Group Announces Launch of Secondary Public Offering
07/05/2026
SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health [...]
AMN Healthcare Announces First Quarter 2026 Results
07/05/2026
Quarterly revenue of $1.378 billion and adjusted EBITDA of $166 million ; GAAP income of $1.59 /share and adjusted EPS of $2.10 DALLAS, May 07, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), the [...]
IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
07/05/2026
Advancing next-generation γδ T cell engager platform with initial animal data expected in 2026 Reported glioblastoma (GBM) data showing ~97% improvement in progression-free survival vs. standard-of-care; updated median [...]
Novi GLP-1 Weight Loss Claims Evaluated: Trusted Semaglutide & Tirzepatide Prescription Medication Treatment Options with Dedicated Doctors
08/05/2026
How Compounded Semaglutide, Compounded Tirzepatide, and GLP-1 Telehealth Prescription Weight Loss Programs Work for Eligible Adults in 2026 Sheridan, WY, May 07, 2026 (GLOBE NEWSWIRE) -- Compounded medications are not [...]

Pages